Genexine Inc. - Net Worth and Insider Trading
Genexine Inc. Net Worth
The estimated net worth of Genexine Inc. is at least $393 Million dollars as of 2024-08-25. Genexine Inc. is the 10% Owner of Rezolute Inc and owns about 91,300,933 shares of Rezolute Inc (RZLT) stock worth over $393 Million. Details can be seen in Genexine Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Genexine Inc. has not made any transactions after 2019-07-23 and currently still holds the listed stock(s).
Transaction Summary of Genexine Inc.
Genexine Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Genexine Inc. owns 1 companies in total, including Rezolute Inc (RZLT) .
Click here to see the complete history of Genexine Inc.’s form 4 insider trades.
Insider Ownership Summary of Genexine Inc.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RZLT | Rezolute Inc | 2019-07-23 | 10 percent owner |
Genexine Inc. Latest Holdings Summary
Genexine Inc. currently owns a total of 1 stock. Genexine Inc. owns 91,300,933 shares of Rezolute Inc (RZLT) as of July 23, 2019, with a value of $393 Million.
Latest Holdings of Genexine Inc.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
RZLT | Rezolute Inc | 2019-07-23 | 91,300,933 | 4.30 | 392,594,012 |
Holding Weightings of Genexine Inc.
Genexine Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Genexine Inc. has made a total of 0 transactions in Rezolute Inc (RZLT) over the past 5 years. The most-recent trade in Rezolute Inc is the acquisition of 34,482,758 shares on July 23, 2019, which cost Genexine Inc. around $10 Million.
Insider Trading History of Genexine Inc.
- 1
Genexine Inc. Trading Performance
GuruFocus tracks the stock performance after each of Genexine Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Genexine Inc. is -68.18%. GuruFocus also compares Genexine Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Genexine Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Genexine Inc.'s insider trading performs compared to the benchmark.
Performance of Genexine Inc.
Genexine Inc. Ownership Network
Ownership Network List of Genexine Inc.
Ownership Network Relation of Genexine Inc.
![Insider Network Chart](https://static.gurufocus.com/insider-network.png)
Genexine Inc. Owned Company Details
What does Rezolute Inc do?
Who are the key executives at Rezolute Inc?
Genexine Inc. is the 10 percent owner of Rezolute Inc. Other key executives at Rezolute Inc include Chief Medical Officer Brian Kenneth Roberts , director & 10 percent owner & Chief Executive Officer Nevan C Elam , and 10 percent owner Handok, Inc. .
Rezolute Inc (RZLT) Insider Trades Summary
Over the past 18 months, Genexine Inc. made no insider transaction in Rezolute Inc (RZLT). Other recent insider transactions involving Rezolute Inc (RZLT) include a net purchase of 46,600 shares made by Brian Kenneth Roberts , a net purchase of 164,351 shares made by Daron Evans , and a net purchase of 115,450 shares made by Young-jin Kim .
In summary, during the past 3 months, insiders sold 0 shares of Rezolute Inc (RZLT) in total and bought 52,866 shares, with a net purchase of 52,866 shares. During the past 18 months, 0 shares of Rezolute Inc (RZLT) were sold and 336,216 shares were bought by its insiders, resulting in a net purchase of 336,216 shares.
Rezolute Inc (RZLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rezolute Inc Insider Transactions
Genexine Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Genexine Inc.. You might contact Genexine Inc. via mailing address: 700 Daewangpangyo-ro, Korea Parkbldg. B, Bundang-gu, Seongnam-si, Gyeonggi-do M5 13488.